Showing results (211-220 of 301) with videos related to

Sort By:
Pageof 31
European Journal of Preventive Cardiology|July 23, 2021
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studiesTahir Mahmood, Jessica Minnier, Matthew K Ito, et al.
Metabolism: Clinical and Experimental|February 25, 2014
Consuming a balanced high fat diet for 16 weeks improves body composition, inflammation and vascular function parameters in obese premenopausal womenHeidi J Silver, Hakmook Kang, Charles D Keil, et al.
Journal of Lipid Research|January 11, 2021
Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9Carlota Oleaga, Joshua Hay, Emma Gurcan, et al.
American Journal of Preventive Cardiology|July 30, 2021
Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statementBruce A Warden, Johannes Steiner, Albert Camacho, et al.
Cardiovascular Therapeutics|October 24, 2017
Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statinSergio Fazio, David G Robertson, Tenshang Joh, et al.
JAMA Network Open|September 12, 2019
A Genetic Approach to the Association Between PCSK9 and SepsisQiPing Feng, Wei-Qi Wei, Sandip Chaugai, et al.
Nature Communications|August 16, 2020
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- miceHuan Tao, Jiansheng Huang, Patricia G Yancey, et al.
Cancer Medicine|July 17, 2023
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trialsKusha A Mohammadi, Taylor Brackin, Gregory G Schwartz, et al.
American Journal of Preventive Cardiology|July 30, 2021
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocolBruce A Warden, Joshua R Miles, Carlota Oleaga, et al.
Journal of Clinical Lipidology|May 31, 2021
Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomesBabikir Kheiri, Timothy F Simpson, Mohammed Osman, et al.
Pageof 31